Matarener's profile picture.

Mark

@Matarener

Mark reposted

Does vitamin B12 play a role in Parkinson’s disease risk? What do the genes tell us? Vitamin B12 metabolism refers to how the body absorbs, transports and uses vitamin B12, which is essential for nerve function and energy production. Dering and colleagues describe in a new paper

MichaelOkun's tweet image. Does vitamin B12 play a role in Parkinson’s disease risk? What do the genes tell us? Vitamin B12 metabolism refers to how the body absorbs, transports and uses vitamin B12, which is essential for nerve function and energy production. Dering and colleagues describe in a new paper

Mark reposted

Left: #valsartan vs placebo in HFrEF (truncated y axis ) Right: #enalapril vs placebo in HFrEF Same primary outcome Enalapril/ACEi then considered gold standard in HFrEF Therefore, appropriate comparator for a new RAASi+ in a #HFrEF RCT in 2009 would be.. ?? #TrialDesign

hvanspall's tweet image. Left: #valsartan vs placebo in HFrEF (truncated y axis )

Right: #enalapril vs placebo in HFrEF

Same primary outcome 

Enalapril/ACEi then considered gold standard in HFrEF

Therefore, appropriate comparator for a new RAASi+ in a #HFrEF RCT in 2009 would be.. ?? 

#TrialDesign
hvanspall's tweet image. Left: #valsartan vs placebo in HFrEF (truncated y axis )

Right: #enalapril vs placebo in HFrEF

Same primary outcome 

Enalapril/ACEi then considered gold standard in HFrEF

Therefore, appropriate comparator for a new RAASi+ in a #HFrEF RCT in 2009 would be.. ?? 

#TrialDesign

See also enalapril instead of similar dose valsartan in HFrEF



Mark reposted

👉 Residual lipid risk in atherosclerotic cardiovascular disease 🙌 MUST READ 1️⃣ Why this matters (still underestimated): Even with optimal LDL-C lowering → residual lipid risk persists. Explains recurrent ASCVD despite “guideline-at-goal” LDL. 2️⃣ Three causal lipid players

drpablocorral's tweet image. 👉 Residual lipid risk in atherosclerotic cardiovascular disease
🙌 MUST READ

1️⃣ Why this matters (still underestimated):
Even with optimal LDL-C lowering → residual lipid risk persists.
Explains recurrent ASCVD despite “guideline-at-goal” LDL.

2️⃣ Three causal lipid players

Mark reposted

New autoantibodies in Sjögren's disease #Rheumatology #MedTwitter These findings strongly suggest that a multi-marker panel approach is the most promising strategy for developing a new diagnostic test for seronegative SjD…

LastManStand85's tweet image. New autoantibodies in Sjögren's disease
#Rheumatology #MedTwitter These findings strongly suggest that a multi-marker panel approach is the most promising strategy for developing a new diagnostic test for seronegative SjD…
LastManStand85's tweet image. New autoantibodies in Sjögren's disease
#Rheumatology #MedTwitter These findings strongly suggest that a multi-marker panel approach is the most promising strategy for developing a new diagnostic test for seronegative SjD…
LastManStand85's tweet image. New autoantibodies in Sjögren's disease
#Rheumatology #MedTwitter These findings strongly suggest that a multi-marker panel approach is the most promising strategy for developing a new diagnostic test for seronegative SjD…

Mark reposted
pash22's tweet image. Does cancer screening increase lifespan?
open.substack.com/pub/breakinggr… via @DrSamuelBHume @susan_bewley @MichaelBaum11 @naserturabi

Mark reposted

Very high lipoprotein(a) levels are associated with increased 30-year risk of major #cardiovascular events, coronary heart disease, ischemic #stroke, and cardiovascular death among healthy women. ja.ma/4kcZvAm

JAMACardio's tweet image. Very high lipoprotein(a) levels are associated with increased 30-year risk of major #cardiovascular events, coronary heart disease, ischemic #stroke, and cardiovascular death among healthy women. 

ja.ma/4kcZvAm

Mark reposted

In this study, nebivolol offers better BP control and lower cardiovascular risk than other beta-blockers. ahajrnls.org/4azyWB7

JAHA_AHA's tweet image. In this study, nebivolol offers better BP control and lower cardiovascular risk than other beta-blockers. ahajrnls.org/4azyWB7

Mark reposted

🧬Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress 1️⃣ PCSK9 LDL-C ↓ via sustained LDLR recycling Proof-of-concept strongest (human genetics → drugs → editing) 2️⃣ ANGPTL3 TG ↓ + LDL-C ↓ (LPL

drpablocorral's tweet image. 🧬Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress

1️⃣ PCSK9
LDL-C ↓ via sustained LDLR recycling
Proof-of-concept strongest (human genetics → drugs → editing)

2️⃣ ANGPTL3
TG ↓ + LDL-C ↓ (LPL
drpablocorral's tweet image. 🧬Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress

1️⃣ PCSK9
LDL-C ↓ via sustained LDLR recycling
Proof-of-concept strongest (human genetics → drugs → editing)

2️⃣ ANGPTL3
TG ↓ + LDL-C ↓ (LPL

Mark reposted

Mineralocorticoid Receptor Antagonist Use in Hypertension to Prevent Heart Failure MRAs may be undervalued for the treatment of hypertension and prevention of HF. The implementation of MRA therapy in earlier phases of hypertension may prevent the incidence of HF by addressing

drbennisahmed's tweet image. Mineralocorticoid Receptor Antagonist Use in Hypertension to Prevent Heart Failure

MRAs may be undervalued for the treatment of hypertension and prevention of HF.

The implementation of MRA therapy in earlier phases of hypertension may prevent the incidence of HF by addressing

Mark reposted

🫀 Treat-to-Plaque Starts with Seeing Plaque Why Photon-Counting CT + High-Iodine Contrast Are Enabling a New Preventive Strategy TRUE Ultra-High spatial resolution TRUE Ultra-High temporal resolution TRUE Ultra-High contrast resolution For decades, we treated numbers: LDL,


Mark reposted
Itsletters_'s tweet image.

Mark reposted
_Angel_broken's tweet image.

Mark reposted

Did you know? There is age adjustment for ESR and CRP - Dr A Dua #RWCS2026

KDAO2011's tweet image. Did you know? There is age adjustment for ESR and CRP - Dr A Dua #RWCS2026

Mark reposted
_Angel_broken's tweet image.

Mark reposted

Quadruple vs triple therapy for resistant hypertension: the QUADRO trial The first full-dose quadruple antihypertensive SPC (perindopril/indapamide/amlodipine/bisoprolol) demonstrated superiority over perindopril/indapamide/amlodipine, offering an effective alternative therapy

drbennisahmed's tweet image. Quadruple vs triple therapy for resistant hypertension: the QUADRO trial

The first full-dose quadruple antihypertensive SPC (perindopril/indapamide/amlodipine/bisoprolol) demonstrated superiority over perindopril/indapamide/amlodipine, offering an effective alternative therapy

Mark reposted

Valacyclovir was associated with greater cognitive decline and did not improve disease markers in patients with symptomatic #AlzheimerDisease and HSV seropositivity. bit.ly/3O6Er2w


Mark reposted

MiniMax just dropped M2.5: - 80.2% SWE-Bench (beats Opus 4.6) - 37% faster than M2.1 - $1/hr at 100 tokens/sec - cheaper than Opus 4.6 - it’s open source.

Introducing M2.5, an open-source frontier model designed for real-world productivity. - SOTA performance at coding (SWE-Bench Verified 80.2%), search (BrowseComp 76.3%), agentic tool-calling (BFCL 76.8%) & office work. - Optimized for efficient execution, 37% faster at complex

MiniMax_AI's tweet image. Introducing M2.5, an open-source frontier model designed for real-world productivity.

- SOTA performance at coding (SWE-Bench Verified 80.2%), search (BrowseComp 76.3%), agentic tool-calling (BFCL 76.8%) & office work.

- Optimized for efficient execution, 37% faster at complex


Mark reposted

What’s the lowest LDL you’ve seen? For everyone shouting that “statins are harmful” and spreading half-baked misinformation… Here’s mine. Yes u read it right MY lipid profile LDL: 9 mg/dL. Yes ! single digit. On a Rosuvastatin for last 3 years. Intermediate ASCVD risk.

nadig_cardio's tweet image. What’s the lowest LDL you’ve seen?

For everyone shouting that “statins are harmful” and spreading half-baked misinformation…
Here’s mine. Yes u read it right MY lipid profile 

LDL: 9 mg/dL. Yes ! single digit.
On a Rosuvastatin for last  3 years.
Intermediate ASCVD risk.

Loading...

Something went wrong.


Something went wrong.